Benefits of Organic India Breathe Free
Asthma & Respiratory Relief
When there is a need to Breathe Free
This Formulation Brings Asthma Relief & Lung Purification
Decongests the pulmonary system and helps repair damaged lung tissues.
- Infections of the respiratory tract including lung infections.
- Respiratory allergies including allergic asthma.
- Bronchial asthma and chronic spasmodic bronchitis.
- Complements the treatment of coronary artery diseases.
Today’s exposure to air pollution in city life and increasing numbers of various allergens, make maintaining clean lungs a priority, for a healthy life Breathe free nourishes and supports the vital respiratory functions.
Each vegetarian capsule of Organic India Breathe Free contains
Pushkarmool (Inula racemosa) - 250mg
- Strong anti – allergic and antihistaminic agent
- Cardio protective against respiratory anoxia.
- Expectorant proprieties
- Potent broncho-dilator
Krishna Tulsi (Ocimum sanctum) - 30 mg
- Antibacterial, antiviral, antifungal, anti-inflammatory immunomodulator, Adaptogen, anti-stress agent.
- Calming effect on central nervous system.
- Provides antioxidant and other nutrients.
Bibhitaki (Terminalia belerica) - 30 mg
- Expectorant, antipyretic
- Mild central stimulation of respiratory centers
- Improves psychosomatic component of asthma
- Relaxes smooth muscles of respiratory tract
Pippali (Piper longum) - 15 mg
- Relief from cough, expectorant
- Protects against allergic bronchospasm
- Centrally improves depressed respiratory component of bronchial disease.
Breathe Free can be taken simultaneously with most allopathic anti-asthmatic drugs without contraindications. Many patients have found that the dosage of allopathic drugs can be decreased gradually until they are no longer necessary.
Dosage of Breathe Free Capsule :
1-2 capsule twice daily with meals, at least for three months. Safe and recommended for long term use. Recommended for long-term use in chronic allergic and bronchial asthma and other forms of COPD.
Recommended for short-term use (1 to 3 weeks) in cases of acute exacerbation of COPD.